MarketInOut Stock Screener Log In | Sign Up
 

Edwards Lifesciences Corp

VIE • Healthcare • Medical Devices • Quote as of 06/25/2026 09:05
Edwards Lifesciences Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeVIE
Market Capitalization43,220 mln
Float574 mln
Earnings Date07/24/2026

EPS

1.61
Stretched

P / E

49.28
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.1
Caution advised

Relative Strength

78 / 100
Strongly outperforming

Debt / Equity

0.07
Debt-free

Business Description

Founded in 1958 and based in Irvine, California, Edwards Lifesciences develops medical devices designed to treat serious heart conditions in patients across the United States and around the world. The company specializes in heart valve therapies, offering both minimally invasive catheter-based solutions and traditional surgical options under several well-known product lines. Its devices help patients suffering from conditions affecting the aortic, mitral, and tricuspid valves, and are sold through its own sales teams as well as independent distributors.

Key Fundamentals

EPS1.61
P/E49.28
ROE10.46
RPS9.28
ROIC16.88
ROA8.08
Interest Cover85.94
EBITDA, mln1,343
EV / EBITDA29.84
EV / EBIT33.28
Revenue, mln5,418
EV / Revenue7.38

Financial Strength

Altman Z-Score12.69
Piotroski F-Score 5 / 9
Beneish M-Score-2.1
Price to Intrinsic Value2.77
Price to Graham Number3.14
Shiller PE Ratio34.21

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.73% 86 / 100   
1 Month 5.22% 75 / 100   
2 Months 8.89% 61 / 100   
6 Months 11.57% 58 / 100   
1 Year 22.4% 63 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us